Distribution of 14 High-Risk HPV Types and p16/Ki67 Dual-Stain Status in Post-Colposcopy Histology Results: Negative, Low- and High-Grade Cervical Squamous Intraepithelial Lesions

被引:0
|
作者
Mazurec, Karolina [1 ]
Trzeszcz, Martyna [1 ,2 ]
Mazurec, Maciej [1 ]
Kobierzycki, Christopher [3 ]
Jach, Robert [4 ]
Halon, Agnieszka [5 ]
机构
[1] Corfamed Womans Hlth Ctr, Kluczborska 37, PL-50322 Wroclaw, Poland
[2] Univ Hosp Wroclaw, Div Pathol & Clin Cytol, Borowska 213, PL-50556 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Human Morphol & Embryol, Div Histol & Embryol, Chalubinskiego 6a, PL-50368 Wroclaw, Poland
[4] Jagiellonian Univ Med Coll, Div Gynecol Endocrinol, Kopern 23, PL-31501 Krakow, Poland
[5] Wroclaw Med Univ, Dept Clin & Expt Pathol, Div Clin Pathol, Borowska 213, PL-50556 Wroclaw, Poland
关键词
cervical cancer screening; human papillomavirus; high-risk HPV; HPV genotyping; cervical intraepithelial neoplasia; p16/Ki67 dual staining; risk stratification; HUMAN-PAPILLOMAVIRUS TYPES; CANCER; WOMEN; GUIDELINES; MANAGEMENT;
D O I
10.3390/cancers16193401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Determining the distribution of high-risk human papillomavirus (HR-HPV) types in histologic low-(LSIL) and high-grade (HSIL/CIN2+) squamous intraepithelial lesions through a diagnostic process in a cervical cancer prevention provides one of the key etiological factors behind further progression and persistence. Incorporating novel high-grade cervical lesion biomarkers such as p16/Ki67 dual staining (DS) alongside HPV typing has become important in detecting cervical precancers.Methods: Among 28,525 screening tests and 602 histology results, 559 cases with HR-HPV and histology results obtained from colposcopic biopsy were retrospectively analyzed, together with DS status. The chi 2 test with Bonferroni correction evaluated the differences in HR-HPV type prevalence and DS positivity across three histologic study groups. Results: A statistically significant difference in the prevalence of HPV 16 was observed between negative and HSIL/CIN2+ (p = 0.00027) groups, as well as between the LSIL/CIN1 and HSIL/CIN2+ groups (p = 0.00041). However, no significant difference was found between the negative and LSIL/CIN1 groups. Similarly, the DS positivity difference was significant between the negative and HSIL/CIN2+ (p < 0.0001) and between the LSIL/CIN1 and HSIL/CIN2+ groups (p < 0.0001), but there was no significant difference between the negative and LSIL/CIN1 groups. Conclusions: The study highlights the heterogeneous nature of HPV-related cervical pathologies, and the distinct risks associated with different cervical lesion grades, emphasizing the importance of HR-HPV type distribution and DS status.
引用
收藏
页数:12
相关论文
共 33 条
  • [31] Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions
    Carcea, Fausto
    Vavoulidis, Eleftherios
    Petousis, Stamatios
    Papandreou, Panagiotis
    Siarkou, Chrysoula Margioula
    Nasioutziki, Maria
    Papanikolaou, Alexios
    Dinas, Konstantinos
    Daniilidis, Angelos
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (10) : 3607 - 3617
  • [32] Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study
    White, Christine M.
    Bakhiet, Salih
    Bates, Mark
    Ruttle, Carmel
    Pilkington, Loretto J.
    Keegan, Helen
    O'Toole, Sharon A.
    Sharp, Linda
    O'Kelly, Ruth
    Tewari, Prerna
    Flannelly, Grainne
    Martin, Cara M.
    O'Leary, John J.
    CANCER EPIDEMIOLOGY, 2020, 68
  • [33] Classification of high-grade cervical intraepithelial neoplasia by p16ink4a, Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management
    Vink, Frederique J.
    Dick, Stefanie
    Heideman, Danielle A. M.
    De Strooper, Lise M. A.
    Steenbergen, Renske D. M.
    Lissenberg-Witte, Birgit I.
    Floore, Arno
    Bonde, Jesper H.
    Ostrbenk Valencak, Anja
    Poljak, Mario
    Petry, Karl U.
    Hillemanns, Peter
    van Trommel, Nienke E.
    Berkhof, Johannes
    Bleeker, Maaike C. G.
    Meijer, Chris J. L. M.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (03) : 707 - 716